A Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBS Trial Phase 1 Not yet recruiting Oct. 25, 2026
MediPD: An Online Mediterranean Diet Program for People Living With Parkinson's Disease Trial N/A Recruiting Oct. 25, 2026
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) Trial N/A Not yet recruiting Oct. 22, 2026
Prevent Cognitive Decline in GBA-associated Parkinson's Disease Trial Phase 2 Recruiting Oct. 22, 2026
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure Trial Phase 1 Terminated Oct. 22, 2026
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease Trial N/A Active, not recruiting Oct. 22, 2026
Randomized Clinical Trial in Parkinson's Disease Patients Using Pluripotent Adipose Stem Cells (PASCs) Trial Phase 1 Completed Oct. 21, 2026
Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes Trial N/A Recruiting Oct. 21, 2026
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Trial Phase 2 Recruiting Oct. 21, 2026
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease Trial Phase 1 Recruiting Oct. 20, 2026
Multimodal Rehabilitation and Balance Assessment in Parkinson's Disease Trial N/A Completed Oct. 20, 2026
Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease Trial N/A Recruiting Oct. 20, 2026
Comparison of Two Different Dual-Task Training Methods in Patients With Parkinson's Disease Trial N/A Completed Oct. 20, 2026
Function-based Accelerated Stimulation Therapy (FAST-therapy) for Freezing of Gait (FOG) After Parkinson's Disease (PD) Trial N/A Not yet recruiting Oct. 19, 2026
Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl Trial N/A Recruiting Oct. 19, 2026
Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes. Trial N/A Active, not recruiting Oct. 19, 2026